All In Biotech

Free tool

FAERS Monitor: Xifaxan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021361 or its brand name (Xifaxan, Rifaximin). Reports on generic versions are filed under their own applications.

Reports

21,335

Serious

16,688

78% of reports

Hospitalization

8,408

Death reported

6,241

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death4,264
  • hospitalisation1,954
  • diarrhoea1,258
  • off label use1,176
  • therapy interrupted1,176
  • ammonia increased862
  • nausea854
  • hepatic encephalopathy836
  • fatigue815
  • drug ineffective752
  • confusional state733
  • insurance issue729
  • hepatic cirrhosis708
  • inability to afford medication707
  • condition aggravated669

Reports by year received

View as table
YearReports
200411
200542
200671
200748
200831
200946
201081
2011115
2012177
2013186
2014294
2015904
20161,653
20172,331
20181,477
20191,813
20201,958
20211,931
20221,771
20232,023
20241,640
20251,328
20261,404

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,032,824 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
ammonia increasedSignal862200.2186.3141,874
hepatic encephalopathySignal83696.990.472,199
inability to afford medicationSignal70775.570.048,218
insurance issueSignal72949.345.832,830
hepatic cirrhosisSignal70838.635.824,925
therapy interruptedSignal1,17616.515.616,857
hospitalisationSignal1,95412.712.220,908
deathSignal4,2644.94.813,723
confusional stateSignal7334.54.21,990
condition aggravatedSignal6692.22.0427
diarrhoea1,2581.91.8573
off label use1,1761.31.397
nausea8541.11.03
fatigue8151.01.01
drug ineffective7520.60.5273

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.